Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Recursion Pharmaceuticals, Inc. (RXRX)  
$9.51 0.27 (2.76%) as of 4:30 Tue 5/21


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 208,280,000
Market Cap: 1.98(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.09 - $15.86
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,693,990
Total Buy Value $0 $0 $0 $12,897,789
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 27
Total Shares Sold 567,946 1,097,598 2,193,115 3,020,700
Total Sell Value $5,420,056 $10,572,222 $21,602,157 $28,825,014
Total People Sold 4 7 8 8
Total Sell Transactions 23 46 97 149
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 628
  Page 1 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gibson Christopher Chief Executive Officer   •       •      –    2024-05-15 4 D $10.01 $261,081 D/D (26,082) 808,738     -
   Mauro David J Chief Medical Officer   •       –      –    2024-05-15 4 D $10.01 $8,679 D/D (867) 243,762     -
   Larson Tina Marriott President and COO   •       –      –    2024-05-15 4 D $10.01 $100,080 D/D (9,998) 533,233     -
   Secora Michael Chief Financial Officer   •       –      –    2024-05-15 4 D $10.01 $119,740 D/D (11,962) 1,219,093     -
   Borgeson Blake Director   –       •      –    2024-05-14 4 AS $10.12 $202,934 D/D (20,054) 7,198,360 -6%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-05-02 4 AS $8.47 $423,500 D/D (50,000) 834,820 7%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-05-02 4 A $0.00 $0 D/D 21,296 856,116     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-05-01 4 AS $7.73 $386,500 D/D (50,000) 863,524 13%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-05-01 4 GD $0.00 $0 D/D 25,000 913,524     -
   Borgeson Blake Director   –       •      –    2024-04-30 4 AS $7.95 $90,964 D/D (11,447) 7,218,414 20%     
   Larson Tina Marriott President and COO   •       –      –    2024-04-25 4 AS $7.67 $23,021 D/D (3,000) 543,231 20%     
   Larson Tina Marriott President and COO   •       –      –    2024-04-25 4 OE $1.06 $3,180 D/D 3,000 546,231     -
   Secora Michael Chief Financial Officer   •       –      –    2024-04-17 4 AS $7.58 $175,349 D/D (23,124) 1,231,055 27%     
   Secora Michael Chief Financial Officer   •       –      –    2024-04-17 4 OE $2.22 $83,250 D/D 37,500 1,254,179     -
   Secora Michael Chief Financial Officer   •       –      –    2024-04-16 4 AS $7.67 $191,658 D/D (25,000) 1,216,679 24%     
   Secora Michael Chief Financial Officer   •       –      –    2024-04-16 4 OE $2.22 $83,250 D/D 37,500 1,241,679     -
   Borgeson Blake Director   –       •      –    2024-04-16 4 AS $7.66 $87,725 D/D (11,447) 7,229,861 24%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-04 4 AS $9.02 $225,500 I/I (25,000) 0 8%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-04 4 A $0.00 $0 I/I 25,000 25,000     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-04 4 AS $9.02 $360,800 D/D (40,000) 938,524 8%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-03 4 AS $8.84 $221,000 I/I (25,000) 0 5%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-03 4 A $0.00 $0 I/I 25,000 25,000     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-03 4 AS $8.84 $353,600 D/D (40,000) 978,524 5%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-04-03 4 GD $0.00 $0 D/D 25,000 1,018,524     -
   Borgeson Blake Director   –       •      –    2024-04-02 4 AS $8.82 $100,942 D/D (11,447) 7,241,308 7%     
  628 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us